Last reviewed · How we verify

NCT02577562

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

APPROVED FOR MARKETING Last updated 24 November 2017
What this trial tests

trial testing Zenith® Fenestrated AAA Endovascular Graft in Abdominal Aortic Aneurysms. Approved for marketing.

Quick facts

Lead sponsorCook Group Incorporated
StatusAPPROVED FOR MARKETING
Study typeEXPANDED_ACCESS
Sites15 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Cook Group Incorporated

Who can join

18 and older, any sex, with Abdominal Aortic Aneurysms or Aorto-iliac Aneurysms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Zenith®Fenestrated AAA Endovascular Graft Clinical Study is a clinical investigation approved by the US FDA to study the safety and effectiveness of the Zenith® Fenestrated AAA Endovascular Graft in the treatment of abdominal aortic and aorto-iliac aneurysms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Abdominal Aortic Aneurysms

Currently open trials in the same condition.

Other Cook Group Incorporated trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02577562.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing